bmy 40062 has been researched along with ofloxacin in 2 studies
| Studies (bmy 40062) | Trials (bmy 40062) | Recent Studies (post-2010) (bmy 40062) | Studies (ofloxacin) | Trials (ofloxacin) | Recent Studies (post-2010) (ofloxacin) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 6,484 | 976 | 1,346 |
| Protein | Taxonomy | bmy 40062 (IC50) | ofloxacin (IC50) |
|---|---|---|---|
| DNA gyrase subunit A | Escherichia coli K-12 | 1.5 | |
| DNA gyrase subunit B | Escherichia coli K-12 | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, NX; Neu, H | 1 |
| Desiderio, JV; Fung-Tomc, J; Kessler, RE; Tsai, YH; Warr, G | 1 |
2 other study(ies) available for bmy 40062 and ofloxacin
| Article | Year |
|---|---|
Comparative in vitro activity of the new fluoroquinolone BMY-40062.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pseudomonas aeruginosa; Staphylococcus; Streptococcus | 1990 |
In vitro and in vivo antibacterial activities of BMY 40062, a new fluoronaphthyridone.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Macrophages; Mice; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 1989 |